No products in the cart.
Pre-made Rivabazumab benchmark antibody ( Fab, anti-PcrV type III secretion system therapeutic antibody) for drug discovery and mechanism of action (MOA) research
Cat:GMP-Bios-ab-488
* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry
Product Details
Pre-Made Rivabazumab biosimilar, Fab: Anti-PcrV type III secretion system therapeutic antibody is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
| Products Name (INN Index) | Pre-Made Rivabazumab biosimilar, Fab: Anti-PcrV type III secretion system therapeutic antibody |
|---|---|
| INN Name | Rivabazumab |
| Target | PcrV type III secretion system |
| Format | Fab |
| Derivation | Humanized |
| Species Reactivity | Human |
| CH1 Isotype | IgG1 |
| VD LC | Kappa |
| Highest_Clin_Trial (Jan '20) | Phase-II |
| Est. Status | Discontinued |
| 100% SI Structure | None |
| 99% SI Structure | None |
| 95-98% SI Structure | None |
| Year Proposed | 2015 |
| Year Recommended | 2016 |
| Companies | KaloBios Pharmaceuticals Inc |
| Conditions Approved | NA |
| Conditions Active | NA |
| Conditions Discontinued | Infectiology,Inflammation,Inherited diseases |
| Development Tech | Humaneering Technology |
| Previous Name | NA |
| Gm Offical Target Name | PcrV type III secretion system |
| Package |
Previous slide
Next slide
